Novo Nordisk: The Bottom Is In
Group 1 - The stock of Novo Nordisk (NVO) has decreased by 10.5% since the last analysis, indicating a potential deep value opportunity for investors [1] - There is a belief that the stock has reached its bottom, prompting consideration for purchasing shares [1] Group 2 - The analysis reflects a personal opinion of the author, who holds a long position in NVO and LLY stocks [2]